FDA demands that vaccines undergo a rigorous and extensive development program in the laboratory, as well as in animal studies and human clinical trials, to determine their safety and effectiveness.

The U.S. Food and Drug Administration announced Oct. 16 that it approved the use of the vaccine Gardasil to prevent genital warts caused by the human papillomavirus types 6 and 11 in males ages 9 to 26.

The U.S. Food and Drug Administration approved use of the seasonal influenza vaccine Fluarix for children ages 3 to 17.

Internet scams are taking advantage of the public’s concern over H1N1, forcing two government agencies to act.

The FDA approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus types 16 and 18.